Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma - a multicenter cohort study
阿特珠单抗联合贝伐珠单抗治疗在初始疾病进展后继续进行:对不可切除肝细胞癌患者的临床获益——一项多中心队列研究
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1653456
Tabuchi, Takaya; Taniki, Nobuhito; Ojiro, Keisuke; Kasuga, Ryosuke; Nakadai, Yukie; Chu, Po-Sung; Usui, Shingo; Shiba, Shunsuke; Tahara, Toshiyuki; Komatsu, Hirokazu; Fujita, Yuriko; Kaneko, Fumihiko; Hoshi, Hitomi; Yamaguchi, Akihiro; Fukuhara, Seiichiro; Okamura, Yukishige; Kanamori, Hideaki; Ebinuma, Hirotoshi; Tamura, Masashi; Tsukada, Jitsuro; Hasegawa, Yasushi; Abe, Yuta; Kitago, Minoru; Jinzaki, Masahiro; Kitagawa, Yuko; Kanai, Takanori; Nakamoto, Nobuhiro